About Forte Biosciences
Forte Biosciences is a company based in Torrance (United States) founded in 2017 by Paul A. Wagner.. The company has 14 employees as of December 31, 2024. Forte Biosciences operates in a competitive market with competitors including ASLAN Pharmaceuticals, Concerto Biosciences, UNION Therapeutics, Biosion and PinCell, among others.
- Headquarter Torrance, United States
- Employees 14 as on 31 Dec, 2024
- Founders Paul A. Wagner
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Forte Biosciences, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-35.48 M-12.71as on Dec 31, 2024
-
EBITDA
$-36.56 M-12.58as on Dec 31, 2024
-
Latest Funding Round
$37.86 M (USD), Post-IPO
Nov 20, 2024
-
Investors
Orbimed
& 6 more
-
Employee Count
14
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Forte Biosciences
Forte Biosciences is a publicly listed company on the NASDAQ with ticker symbol FBRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Forte Biosciences
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $37.9M
-
First Round
First Round
(15 Jun 2020)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Post-IPO - Forte Biosciences | Valuation |
investors |
|
| Aug, 2023 | Amount | Post-IPO - Forte Biosciences | Valuation |
investors |
|
| Jun, 2020 | Amount | Post-IPO - Forte Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Forte Biosciences
Forte Biosciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed, Janus Henderson Investors and Alger. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
ESG investments are managed by this venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Forte Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Forte Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Forte Biosciences Comparisons
Competitors of Forte Biosciences
Forte Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ASLAN Pharmaceuticals, Concerto Biosciences, UNION Therapeutics, Biosion and PinCell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted small molecules are developed for oncology treatments.
|
|
| domain | founded_year | HQ Location |
Microbe-based products are developed for agriculture and human health.
|
|
| domain | founded_year | HQ Location |
Small molecule antibiotics are developed for bacterial infections.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Developer of anti-inflammatory therapy for the treatment skin diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Forte Biosciences
Frequently Asked Questions about Forte Biosciences
When was Forte Biosciences founded?
Forte Biosciences was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Forte Biosciences located?
Forte Biosciences is headquartered in Torrance, United States. It is registered at Torrance, California, United States.
Who is the current CEO of Forte Biosciences?
Paul A. Wagner is the current CEO of Forte Biosciences. They have also founded this company.
How many employees does Forte Biosciences have?
As of Dec 31, 2024, the latest employee count at Forte Biosciences is 14.
What does Forte Biosciences do?
Forte Biosciences was founded in 2017 and is based in Torrance, United States. Operations focus on the biotechnology sector, where therapeutic solutions for inflammatory skin diseases are developed. The lead product, FB-401, is a topical formulation derived from strains of the commensal gram-negative bacteria Roseomonas mucosa. This approach targets treatment of conditions such as atopic dermatitis through microbial-based therapies.
Who are the top competitors of Forte Biosciences?
Forte Biosciences's top competitors include ASLAN Pharmaceuticals, Concerto Biosciences and UNION Therapeutics.
Is Forte Biosciences publicly traded?
Yes, Forte Biosciences is publicly traded on NASDAQ under the ticker symbol FBRX.
Who are Forte Biosciences's investors?
Forte Biosciences has 7 investors. Key investors include Orbimed, Janus Henderson Investors, Alger, Tybourne Capital Management, and Ikarian Capital.
What is Forte Biosciences's ticker symbol?
The ticker symbol of Forte Biosciences is FBRX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.